Lemaitre Vascular (LMAT) Tops Q3 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 hits record high as rate-hike worries ease
- Oil pares losses after reports Houthis attacked Saudi Aramco refinery
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Burry doubles down on Nebius short after stock surges 34% on earnings
- Exclusive-Silver Lake in talks to buy Workday, sources say
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Home Depot CEO Ted Decker takes medical leave; two executives step in
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
LeMaitre Vascular (LMAT) PT Raised to $16.50 at Canaccord Genuity Following 'Another Outstanding Quarter'
October 28, 2015 9:59 AM EDTCanaccord Genuity analyst Jason Mills reiterated a Buy rating and raised his price target on LeMaitre Vascular (NASDAQ: LMAT) to $16.50 (from $14.50) following "another outstanding quarter."
Mills commented, "Buy LMAT. We reiterate this bullish stance following another outstanding beat-andraise quarter highlighted by strong sales across all major... More
Barrington Research Upgrades LeMaitre Vascular (LMAT) to Outperform
October 28, 2015 9:49 AM EDTBarrington Research upgraded LeMaitre Vascular (NASDAQ: LMAT) from Market Perform to Outperform with a price target of $14.00.
For an analyst ratings summary and ratings history on LeMaitre Vascular click here. For more ratings news on LeMaitre Vascular click here.
Shares of LeMaitre Vascular closed at $12.73 yesterday.
... More